GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (ASX:CUV) » Definitions » Cash Payments for Deposits by Banks and Customers

Clinuvel Pharmaceuticals (ASX:CUV) Cash Payments for Deposits by Banks and Customers


View and export this data going back to 2001. Start your Free Trial

What is Clinuvel Pharmaceuticals Cash Payments for Deposits by Banks and Customers?

Cash Payments for Deposits by Banks and Customers only applies to banks.


Clinuvel Pharmaceuticals (ASX:CUV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (ASX:CUV) » Definitions » Cash Payments for Deposits by Banks and Customers
Traded in Other Exchanges
Address
535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000
Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.